Papers on alogliptin

13 papers2 new in 30 days

Tuesday, October 27

Diabetes, Obesity, and Cardiometabolic CAREOct 27

Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation

Cohort study of 115,091 peopleType 2 diabetes

Paper

Monday, October 26

ESC Congress 2026 AbstractOct 26

Incremental cardiovascular benefit of GLP-1RA added to SGLT2i in type 2 diabetes: a target trial emulation in the US veterans health administration

Cohort study of 79,792 peopleType 2 diabetes

Paper

Friday, March 13

Journal of Medicinal ChemistryMar 13

Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes

Experiments in animalsType 2 diabetes

Paper

Friday, February 27

Naunyn-Schmiedeberg's Archives of PharmacologyFeb 27

Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance study

Study of 15,052 peopleMusculoskeletal disease

Paper

Thursday, November 6

Journal of Personalized MedicineNov 6

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review

Systematic review of studies in peopleType 2 diabetes

Paper

Monday, December 23

bioRxivDec 23

Cross-disease modeling of peripheral blood identifies biomarkers of type 2 diabetes predictive of Alzheimer's disease

Preprint: computational studyBiomarkers

Paper

Thursday, January 12

Journal of Basic and Clinical Physiology and PharmacologyJan 12

Anti-ageing effects of FDA-approved medicines: a focused review

ReviewInterventions

Paper

Tuesday, March 22

Diabetes, Obesity & MetabolismMar 22

Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC)

Randomized trial in 1,088 peopleType 2 diabetes

Paper

Monday, August 17

International Journal of Molecular SciencesAug 17

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans

Experiments in cellsInterventions

Paper

Monday, October 28

Drug SafetyOct 28

Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus

ReviewInterventions

Paper

Tuesday, September 17

Journal of Clinical Medicine ResearchSep 17

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus

Study in peopleInterventions

Paper

Tuesday, January 15

Aging CellJan 15

Alogliptin improves survival and health of mice on a high-fat diet

Experiments in miceInterventions

Paper

Wednesday, December 5

Endocrine JournalDec 5

Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin

Non-randomized trial in 10 peopleHyperglycemia

Paper